🧫
Literature Review of TRT-Induced Erythrocytosis Risk
active
experiment
Created: 2026-04-06T12:30:56
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-06bb3d1a-bab3-4bd0-bd64-68d35ed10d5a
🧫 Experiment Protocol
Clinicalhypogonadismhuman patientsproposed
A comprehensive literature review examining the relationship between testosterone replacement therapy (TRT) and the development of erythrocytosis and polycythemia in aging males with hypogonadism. The study analyzed existing published research to assess the mechanisms, risk factors, and clinical implications of TRT-induced increases in hemoglobin and hematocrit levels. The review specifically focused on the 315% increased risk of erythrocytosis development in men receiving TRT compared to controls, with particular attention to the potential for venothromboembolism (VTE) as highlighted by recent FDA warnings. The analysis examined various aspects including basic science mechanisms, different pharmacologic preparations of testosterone, routes of delivery, and the relationship between hematocrit levels and thrombotic event risk.
PRIMARY OUTCOME
erythrocytosis and polycythemia incidence
EXPECTED OUTCOMES
Quantification of erythrocytosis risk associated with TRT and identification of mechanisms underlying this response
SUCCESS CRITERIA
Comprehensive assessment of TRT-induced hematologic changes and risk stratification
PROTOCOL
Literature review through PubMed database search focusing on TRT, erythrocytosis, and polycythemia studies
Source: PMID 27784544 ↗
🧫 Experiment Extras
PATHWAY
androgen signaling pathway
MARKET PRICE
$0.50
STATUS
proposed
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.